Frazis Capital Partners
Internal research and company updates
But that doesn't mean it's safe
Software winter, AI spring
November 2025 Investment Update
A decisive turn in US biotech
September investment update and a new investment in US healthcare
A conversation with CEO Dr Chris Burns
And Microsoft replaces ~$20 billion of capex with a signature
Semis, superclusters, and next-generation biotech. Is the suffering finally over for gene therapies?
And some good news from Skin2Neuron